PETALING JAYA: The Johnson & Johnson’s single dose vaccine may be too little and too late for Malaysia, and this is a concern currently being addressed by the government with the manufacturer, says Khairy Jamaluddin. First is the number of doses that are on offer from Johnson & Johnson.They are not offering us that many and that’s quite disappointing. “We have raised this with Johnson & Johnson as a concern, that they are prioritising the rich countries and we get the back-end of it this year, and that the doses on offer are not that much – just slightly above two million doses, ” Khairy toldThe Star in a virtual interview recently. “In terms of cost, Johnson & Johnson is the most competitively priced vaccine, ” said Khairy. Malaysia received the first batch of China’s CoronaVac vaccine, developed by Sinovac Life Sciences Co Ltd, last Saturday.

Source: The Star March 02, 2021 23:34 UTC